Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Gastrointestinal Issues Many individuals who start GLP-1 therapies report gastrointestinal symptoms
Patients with heart failure, kidney disease, or other conditions requiring fluid restriction should follow their healthcare provider's specific guidance on fluid intake
Patients inject into the abdomen, thigh, or upper arm, rotating sites with each dose
These agents can affect the intestinal immune system and alter microbial composition via activation of the sympathetic nervous system, through mechanisms such as norepinephrine release, which has been associated with increased levels of bacteria like Escherichia coli [84]
US$ 24.84
US$ 23.59
US$ 23.34
US$ 28.17
